Related Experiment Video
Updated: Jun 19, 2026
08:37
Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
CARD4/NOD1 is not involved in inflammatory bowel disease
Gut
|December 13, 2002
Summary
The CARD4 gene was investigated for its role in inflammatory bowel diseases (IBD). Genetic analysis revealed no significant association between CARD4 variants and IBD susceptibility or phenotype.
Area of Science:
- Genetics
- Immunology
- Gastroenterology
Background:
- Inflammatory bowel diseases (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are complex genetic disorders.
- CARD15/NOD2 is linked to CD predisposition, but other genetic factors are implicated.
- CARD4/NOD1 shares similarities with CARD15/NOD2, prompting investigation into its role in IBD.
Purpose of the Study:
- To investigate the potential role of CARD4/NOD1 in the genetic susceptibility to IBD.
- To screen CARD4 for genetic variations and assess their association with IBD.
Main Methods:
- Screening of CARD4 gene exons for variants in 63 IBD patients.
- Genotyping of a specific non-private CARD4 variant in 381 IBD families using PCR-RFLP.
- Analysis of genotyping data using the transmission disequilibrium test.
Main Results:
- Nine sequence variations were identified in CARD4, with five causing non-conservative amino acid substitutions.
- The E266K variant, with an allele frequency of 0.28, showed no association with CD, UC, or IBD.
- No significant difference in phenotype was observed between IBD patients with and without CARD4 sequence variations.
Conclusions:
- CARD4 does not appear to play a significant role in the genetic susceptibility to IBD.
- Further research may be needed to identify other genetic factors contributing to IBD.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...